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The neuronal glycine transporter GlyT2 plays a fundamental role in the glycinergic neurotransmission by recycling the neurotransmitter
to the presynaptic terminal. GlyT2 is the main supplier of glycine for vesicle refilling, a process that is absolutely necessary to preserve
quantal glycine content in synaptic vesicles. Alterations inGlyT2 activitymodify glycinergic neurotransmission andmayunderlie several
neuromuscular disorders, such as hyperekplexia, myoclonus, dystonia, and epilepsy. Indeed, mutations in the gene encoding GlyT2 are
themain presynaptic cause of hyperekplexia in humans and produce congenitalmuscular dystonia type 2 (CMD2) in Belgian Blue cattle.
GlyT2 function is strictly coupled to the sodium electrochemical gradient actively generated by the Na/K-ATPase (NKA). GlyT2
cotransports 3Na/Cl/glycinegenerating large rises ofNa inside thepresynaptic terminal thatmustbe efficiently reducedby theNKA
to preserveNa homeostasis. In this work, we have used high-throughputmass spectrometry to identify proteins interactingwith GlyT2
in the CNS. NKA was detected as a putative candidate and through reciprocal coimmunoprecipitations and immunocytochemistry
analyses the association between GlyT2 andNKAwas confirmed. NKAmainly interacts with the raft-associated active pool of GlyT2, and
low and high levels of the specific NKA ligand ouabainmodulate the endocytosis and total expression of GlyT2 in neurons. The ouabain-
mediated downregulation of GlyT2 also occurs in vivo in two different systems: zebrafish embryos and adult rats, indicating that this
NKA-mediated regulatorymechanism is evolutionarily conserved andmay play a relevant role in the physiological control of inhibitory
glycinergic neurotransmission.
Introduction
Inhibitory glycinergic neurotransmission is terminated by spe-
cific glycine transporters GlyTs (GlyT1 and GlyT2), which ac-
tively reuptake glycine from the synaptic cleft. The neuronal
transporter GlyT2 additionally recycles the neurotransmitter to
the presynaptic terminal, a process that is absolutely necessary to
preserve quantal glycine content inside synaptic vesicles (Go-
meza et al., 2003b; Rousseau et al., 2008; Apostolides and Trus-
sell, 2013). Gene deletion studies suggest that GlyT alterations
may underlie several human disorders, such as hyperekplexia,
myoclonus, pain, and epilepsy (Gomeza et al., 2003a, 2003b;
Arago´n and Lo´pez-Corcuera, 2005). Indeed, mutations in the
gene encoding GlyT2 are the secondmain cause of hyperekplexia
in humans (Eulenburg et al., 2006; Rees et al., 2006; Carta et al.,
2012; Gimenez et al., 2012) and produce congenital muscular
dystonia type 2 (CMD2) in Belgian Blue cattle (Gill et al., 2012).
Membrane protein trafficking plays a fundamental role in con-
trolling neuronal activity, and it is a key regulatory mechanism
for several neurotransmitter transporters by providing a rapid
and transient way to modulate its activity (Blakely and Bauman,
2010). GlyT2 constitutively recycles between the cell surface and
intracellular compartments, andmodulation ofGlyT2 trafficking
is achieved by several factors in a regulated manner (Geerlings et
al., 2001; Forne´s et al., 2008; de Juan-Sanz et al., 2011, 2013).
Glycine transporters are sodium-dependent proteins function-
ally coupled to the sodium electrochemical gradient, which is
actively generated and maintained by Na/K-ATPase (NKA).
GlyT2 cotransports 3Na/Cl/glycine (Lo´pez-Corcuera et al.,
1998; Roux and Supplisson, 2000), generating large rises in intra-
cellular Na that must be efficiently reduced by the NKA to
preserve ion homeostasis, which is absolutely necessary for syn-
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aptic transmission and neuronal excitability. Recent research has
elucidated that NKA also functions as a receptor involved in
many signaling events (recent reviews: Lingrel, 2010; Liu andXie,
2010; Benarroch, 2011; Reinhard et al., 2013). Cardiotonic ste-
roids (CTSs) are specific inhibitors of the NKA found in plants
and vertebrates, and they are also produced endogenously in the
human adrenal cortex and hypothalamus (Hamlyn et al., 1991;
Tymiak et al., 1993; el-Masri et al., 2002). Low concentrations of
ouabain and marinobufagenin can be detected in human blood
similarly to endogenously produced hormones (Ludens et al.,
1991; Bagrov et al., 2009), and the binding of these CTS to NKA
subunits triggers downstream signaling events leading to the
modulation of different cellular processes.
Here we have identified NKA as a GlyT2-interacting protein
in synaptosomes and primary neurons from rat brainstem and
spinal cord. GlyT2-NKA interaction is compartmentalized in
lipid rafts, where GlyT2 is optimally active (Nu´n˜ez et al., 2008),
suggesting that NKA might regulate the local presynaptic Na
increases produced during glycine recapture by GlyT2. Inhibi-
tion of NKA activity by low concentrations of ouabain causes
internalization ofGlyT2, whereas high concentrations of ouabain
elicited a drastic lysosomal degradation of the active lipid raft-
associated transporter. Ouabain-mediated degradation of GlyT2
is also observed in zebrafish embryos and in adult rats, indicating
the existence of an evolutionarily conserved NKA-mediated
mechanism that regulates glycinergic neurotransmission by
modulating GlyT2 expression in vivo.
Materials andMethods
Materials
Zebrafish embryos of either sex and male Wistar rats were bred under
standard conditions at theCentro deBiologíaMolecular SeveroOchoa in
accordance with the current guidelines for the use of animals in neuro-
scientific research. All animal procedures were approved by the institu-
tional animal care and performed according to European Union
guidelines (Council Directive, 2010/63/EU). Antibodies against GlyT2
were obtained in house (rabbit and rat) (Zafra et al., 1995; Nu´n˜ez et al.,
2009), whereas the other primary antibodies used were as follows: anti-
1NKA (1:500, mouse monoclonal, clone C464.6; Millipore Bioscience
Research Reagents); anti-1NKA (goat polyclonal; Santa Cruz Biotech-
nology); anti-1NKA (mouse monoclonal, clone 6F; DHSB; only used
for IP); anti-2 NKA (1:500, rabbit polyclonal; Millipore Bioscience Re-
search Reagents); anti-3NKAused for zebrafish (1:1000,mousemono-
clonal; Affinity BioReagents); anti-3 NKA (1:500, goat polyclonal;
Santa Cruz Biotechnology); anti-1 NKA (1:500, rabbit polyclonal;
Thermo Scientific); anti-2NKA (1:500, rabbit polyclonal; Sigma); anti-
Thy-1 (1:500, mouse monoclonal; BD Biosciences PharMingen); anti-
flotillin1 (1:500, mouse monoclonal; BD Biosciences); anti-clathrin
heavy chain (1:500, mouse monoclonal; BD Transduction); anti-3 tu-
bulin (1:1000, mouse monoclonal; Sigma-Aldrich); and anti-tubulin for
zebrafish (mouse monoclonal, clone 6G7s; DHSB). Fluorophore-
coupled secondary antibodies were acquired from Invitrogen. All the
chemicals used were obtained from Sigma-Aldrich, and the Neurobasal
medium and B-27 supplement were purchased from Invitrogen. The
monoclonal antibody (clone 6G7) used for zebrafish tubulin detection
was generated by Dr Willi Halfter (University of Pittsburgh), and the
monoclonal antibody (clone 6F) anti-1NKA was generated by Dr
Douglas M. Fambrough (Johns Hopkins University). Both these anti-
bodies were obtained from the Developmental Studies Hybridoma Bank
developed under the auspices of the NICHD and maintained by the
University of Iowa (Department of Biology, Iowa City, IA). Expression
vectors for the rat 1, 2, and 3 NKAs were generously donated by Dr
Jerry B. Lingrel (University of Cincinnati).
Protein identification by liquid chromatography coupled to
tandem mass spectrometry
Protein in-gel digestion. Protein identification in immunoprecipitates was
performed following a previously published strategy (Pe´rez-Herna´ndez
et al., 2013). Approximately 40 l of immunoprecipitated beads was
suspended in 10 l of sample buffer (5% SDS, 10% glycerol, 25 mM
Tris-Cl, pH 6.8, 10 mM DTT, 0.01% bromophenol blue). Proteins re-
tained by the beads were digested using a previously described protocol
(Bonzon-Kulichenko et al., 2011). The samples were applied onto 2.8-
cm-wide wells of a conventional SDS-PAGE gel (0.5mm thick, 4% stack-
ing, 10% resolving). The run was stopped as soon as the front entered 3
mm into the resolving gel so that the whole proteome was concentrated
in the stacking/resolving gel interface. The protein bandwas visualized by
Coomassie staining, excised, cut into cubes, and digested overnight at
37°C with 60 ng/l trypsin at a 5:1 protein:trypsin (w/w) ratio in 50 mM
ammonium bicarbonate, pH 8.8, containing 10% acetonitrile and 0.01%
5-cyclohexyl-1-pentyl- D-maltoside. The resulting tryptic peptides
from each proteome were then extracted by 1 h incubation in 12 mM
ammonium bicarbonate, pH 8.8. Trifluoroacetic acid was added to a
final concentration of 1%, and the peptides were finally desalted onto
C18 Oasis cartridges and dried. The resulting peptides from each gel
band were analyzed separately by reversed phase HPLC-LIT for protein
identification.
Mass spectrometry and data analysis. To identify proteins, the resulting
tryptic peptide mixtures were analyzed by nanoliquid chromatography
coupled to mass spectrometry. Peptides were injected onto a C-18 re-
versed phase nanocolumn (100 m ID and 15 cm, Mediterranea Sea
Teknokroma) and analyzed on a continuous acetonitrile gradient of
0–43% B for 90 min and 50–90% B for 1 min (B  95% acetonitrile,
0.1% formic acid). Peptides were eluted from the reversed phase nano-
column at a flow rate of 200 nl/min for real-time ionization, and peptide
fragmentation was performed on an LTQ-Orbitrap mass spectrometer
(Thermo Fisher). An enhanced FT-resolution spectrum (resolution 
30,000) and the MS/MS spectra of the 15 most intense parent ions were
analyzed during the chromatographic run (150min).Dynamic exclusion
was set at 0.5 min.
TheMaxQuant software package (version 1.0.3.5) was used to identify
the proteins (Cox and Mann, 2008; Cox et al., 2009). Peptides were
searched against the rat database (IPI.Rat, version 3.84) containing com-
mon contaminants using Andromeda. Carbamidomethylation of cys-
teine was selected as a fixed modification, and oxidation of methionine
and acetylation of the protein N terminus was used as variable modifica-
tion. Trypsin was selected as protease (full specificity) with a maximum
of twomissed cleavages. Amass tolerance of 0.6Dawas used for fragment
ions. A minimum of seven amino acids per identified peptide was re-
quired. The false discovery rate threshold was set to 1% at both the
peptide and protein levels.
Rubidium-86 uptake by neurons
Rubidium-86 uptake by neurons was used to measure the potassium ion
pumping activity of NKA. Neurons were maintained in Neurobasal me-
dium containing different concentrations of ouabain for 15 min at 37°C.
Themediumwas then replaced with Neurobasal medium containing 1.5
Ci/ml (55.5 Bq/ml) of 86Rb (PerkinElmer Life and Analytical Sci-
ences) and the previous concentrations of ouabain. The uptake assay was
allowed to proceed for 10min, and the incubationwas stopped by rinsing
the plate four times with cold PBS. The cells were extracted with 0.25 ml
of 0.2 mM NaOH for 10 min, and the samples were counted in a liquid
scintillation counter to measure the radiation from the incorporated
-emitting 86Rb isotopes. Each data point represents the average radio-
activity present in nine separate wells from three different experiments.
Immunoprecipitation
Synaptosomes or primary neurons from the brainstem or spinal cord
(100 g) were lysed for 30 min at room temperature (RT) at a concen-
tration of 0.35 mg of protein/ml in TN buffer (25 mM Tris-HCl and 150
mMNaCl, pH 7.4) containing 0.25%NP-40 and protease inhibitors (PIs:
0.4 mM PMSF  Sigma mixture). After 15 min centrifugation in a Mi-
crofuge to remove the cell debris, 4g of protein was separated to quan-
14270 • J. Neurosci., August 28, 2013 • 33(35):14269–14281 de Juan-Sanz et al. • Downregulation of GlyT2 by Na/K-ATPase Interaction
tify total protein (T), and 5–10l of the primary antibody was added and
left overnight at 4°C using the following antibodies for immunoprecipi-
tation: rat or rabbit anti-GlyT2, mouse anti-1 NKA (clone 6F), rabbit
anti-2 NKA, goat anti-3 NKA, rabbit anti-1 NKA, or rabbit anti-2
NKA. A negative control was also run in parallel in which an irrelevant
antibody was added, denoted as IgG. Subsequently, 20l of 50% protein
A-Sepharose beads for rabbit antibodies or protein G-Sepharose beads
for rat,mouse, or goat antibodies were added and incubated for 45min at
4°C. The beads were collected by mild centrifugation and washed twice
for 7 min with lysis buffer at RT. Finally, the beads were pelleted, and the
immunoprecipitated proteins were eluted in Laemmli buffer at 75°C for
10 min, resolved in SDS-PAGE gels (7.5%), detected inWestern blots by
enhanced chemiluminescence, and quantified on a GS-710 calibrated
imaging densitometer (Bio-Rad).
Lipid raft isolation
Membrane rafts were isolated from brainstem and spinal cord synapto-
somes or primary neurons as described previously (de Juan-Sanz et al.,
2011). Briefly, washed and scraped neurons or purified synaptosomes (2
mg of protein/ml) were lysed in MBS buffer (25 mM MES and 150 mM
NaCl, pH 6.5) containing 0.35% Triton X-100 and PIs (0.4 mM PMSF
Sigma mixture), and solubilized by passing them through a 25-gauge
needle and left at 4°C for 30 min. Equal volumes of 70% (w/v) sucrose
were then added to the lysates, and they were mixed thoroughly before
overlaying 1 ml of the sample successively with 2 ml of 30% and 1 ml of
5% sucrose (in MBS  PI) in Ultra-Clear Beckman tubes suitable for
centrifugation in a TST 60.4 rotor. After 18 h of 52,000 rpm ultracentrif-
ugation at 4°C, the raft fractions (R) were collected from the 5–30%
sucrose interphase while the nonraft fractions from the last 35% of the
phase (NR). Both the R and NR were solubilized for 30 min at RT in
0.25% NP-40 to disrupt raft structure, and the proteins recovered were
analyzed byWestern blot or they were immunoprecipitated as indicated
above. To ensure the correct isolation, flotillin1 and clathrin heavy chain
were used as raft and nonraft markers, respectively.
Primary cultures of brainstem and spinal cord neurons
Primary cultures of brainstem and spinal cord neurons were prepared as
described previously (de Juan-Sanz et al., 2013). Briefly, the brainstem
and spinal cord of Wistar rat fetuses were obtained at the 16th day of
gestation, and the tissue was then mechanically disaggregated in HBSS
(Invitrogen) containing 0.25% trypsin (Invitrogen) and 4 mg/ml DNase
(Sigma). Cells were plated at a density of 500,000 cells/well in 12 well
multiwell plates (Falcon), and they were incubated for 4 h in DMEM
containing 10% FCS, 10 mM glucose, 10 mM sodium pyruvate, 0.5 mM
glutamine, 0.05mg/ml gentamicin, 0.01% streptomycin, and 100U/ml
penicillin G. After 4 h, this buffer was replaced with Neurobasal/B27
culture medium containing 0.5 mM glutamine (50:1 by volume: Invitro-
gen), and 2 d later cytosine arabinoside (2.5–5 M) was added to inhibit
further glial growth. These primary neurons were used for study after
14–21 d in culture.
Immunofluorescence of brainstem and spinal cord
primary neurons
Primary neurons were fixed with 4% paraformaldehyde in PBS, washed
three times with 1 ml PBS, and then blocked for 30 min with 10% serum
in TNT (0.1 M Tris/HCl, pH 7.5, 0.3 M NaCl, and 0.2% Triton). The
neurons were then incubated for 2 h with the primary anti-GlyT2 rat
antibody (1:500) together with the following: anti-1 NKA (1:500),
anti-2 NKA (1:500), anti-3 NKA (1:500), or Thy-1 (1:500) diluted in
TNT containing 1% serum. The cells were then washed three times with
TNT buffer and incubated for 2 h with the secondary antibody diluted
in TNT with 1% serum (anti-rat AlexaFluor-594, 1:500; anti-mouse
AlexaFluor-488, 1:500; anti-rabbit AlexaFluor-594, 1:500). After three
washes with TNT, the coverslips were mounted on microscope slides
with Vectashield (Vector Laboratories) and the cells were visualized by
confocal microscopy on an invertedmicroscope AXIOVERT200 (Zeiss).
Immunofluorescence of brainstem and spinal cord synaptosomes
Purified brainstem and spinal cord synaptosomes were analyzed by dou-
ble immunofluorescence as reported previously (Jime´nez et al., 2011),
using primary antibodies against GlyT2 and the different NKA
-subunits. The synaptosomes were visualized under a confocal micro-
scope as indicated above.
Immunofluorescence quantification and generation of color maps
At least 40 images for each treatment condition were quantified using
ImageJ software (National Institutes of Health). Images were processed
with a 2.0 pixel median filter, and the threshold used was automatically
determined by the JACoP plugin (Bolte and Cordelie`res, 2006). The
Pearson’s value was obtained with JACoP by comparing the two thresh-
olded channels and measuring the correlation between them. The value
can range from1 to 1, with 1 representing the maximal colocalization
possible (two identical images) and values 0.5 usually considered as
valid colocalization (Zinchuk and Zinchuk, 2008). Colocalization color
mapswere generated in ImageJ using the colocalization colormap plugin
(Jaskolski et al., 2005).
Whole-mount immunofluorescence of zebrafish embryos
Manually dechorionated 48 hpf zebrafish embryos were fixed for 1 h in
4% PFA at RT, washed three times with PBS, and blocked for 1 h with
10% serum in PBS containing 0.55% Triton X-100. The fixed embryos
were incubated with the primary anti-GlyT2 rabbit antibody (1:200) and
the anti-3NKAmouse antibody (1:200) in PBS containing 1% serum at
4°C for 3 d with gentle rotation. The embryos were then washed three
times with PBS and incubated for 4 h with the secondary antibodies in
PBS with 1% serum (anti-rabbit AlexaFluor-594 1:500, red; anti-
mouse AlexaFluor-488 1:500, green). After three washes with PBS, the
embryos were visualized under a stereoscopic magnifying glass
(Leica) or they were mounted on coverslips with Vectashield (Vector
Laboratories) and visualized by confocal microscopy on an inverted
microscope AXIOVERT200 (Zeiss).
Zebrafish embryo incubations with ouabain
Manually dechorionated 48 hpf zebrafish embryos were incubated with
100 M ouabain diluted in E3 medium (5 mM NaCl, 0.17 mM KCl, 0.33
mM CaCl2, 0.33 mMMgSO4, and 0.1%methylene blue) or with the vehi-
cle alone (n 7 embryos per point, performed in triplicate). After a 6 h
incubation with slow shaking, the embryos were collected, lysed in 95°C
Laemmli buffer for 5 min, sonicated, and the proteins resolved on SDS-
PAGE gels (7.5%). GlyT2 expression was assessed in Western blots
probed with an anti-GlyT2 rabbit primary antiserum and with a
peroxidase-linked anti-rabbit IgG. Antibody binding was visualized by
enhanced chemiluminescence and quantified on a GS-710 calibrated
imaging densitometer (Bio-Rad).
Intramedullar administration of ouabain in adult Wistar rats
Young adult maleWistar rats (295–315 g, 12 weeks of age) were anesthe-
tized with an intraperitoneal injection of sodium thiobarbital (40mg/kg)
and xylacine (10 mg/kg). Once the absence of reflexes was confirmed, a
dorsal midline incision was made into the skin and thoracic vertebra 8
(T8) was exposed after dissection of themuscle. The spiny apophysis and
dorsal lamina of T8 were removed, exposing the spinal cord. Intramed-
ullar injections (2 l of 1 mM ouabain per animal) were applied to this
section using a Hamilton glass micro-needle syringe (Hamilton). Sham-
operated animals underwent the same laminectomy protocol but were
injected with the vehicle alone. In both cases, the injection sites were
identified by the deposition of a trypan blue dye (0.5 mg/ml, Sigma).
Three hours after the administration, the animals were killed, and differ-
ent sections of the spinal cord (cervical vertebra 4 [C4], T8, and thoracic
vertebra 12 [T12]) were extracted, lysed, and analyzed in Western blots.
Results
Given the importance of GlyT2 in the pathophysiology of inhib-
itory glycinergic neurotransmission and considering the small
number of proteins currently known to interact with this trans-
porter, we performed a proteomic study to identify newmolecu-
lar partners involved in the functional modulation of GlyT2.
Accordingly, we immunoprecipitated the native transporter
from brainstem and spinal cord synaptosomes with a specific
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GlyT2 antibody (Zafra et al., 1995) and identified associated pro-
tein partners by high-throughput mass spectrometry. In these
assays, the number of peptides and total spectral counts detected
that corresponded to nonspecific binding proteins were similar
when the immunoprecipitation was performed using the anti-
GlyT2 antibody, a nonrelated rabbit IgG, or Sepharose beads
alone (e.g., 4 tubulin; Fig. 1A). However, we found that the
anti-GlyT2 antibody specifically enhanced the detection of a
higher number of spectral counts belonging to the NKA subunits
(Fig. 1A). NKA is mainly composed of a catalytic -subunit that
contains the binding sites for ATP, Na, K, and CTS selective
inhibitors and a heavily glycosylated  subunit. In some tissues,
this enzyme is associated with a member of the FXYD family
named the -subunit. We found in GlyT2 immunoprecipitates
spectral counts corresponding to catalytic subunits 1, 2, and
3, and accessory subunits 1 and 2 with a higher level corre-
sponding to -subunits (Fig. 1A). However, the lower detection
of -subunits could be explained because they are highly glyco-
sylated proteins and this condition can reduce the amount of the
spectral counts. Therefore, this first mass spectrometry result
indicated that GlyT2 could be interacting with , , or both
subunits (representative tandem mass spectra of 1NKA-,
2NKA-, and 3NKA-specific peptides obtained in these assays
are shown in Fig. 1B–D).
GlyT2 interacts with NKA in synaptosomes
To confirmGlyT2-NKA interaction, we performed reverse coim-
munoprecipitations from rat brainstem and spinal cord synapto-
somal lysates with specific antibodies directed against GlyT2 and
1, 2, 3, 1, and 2 NKA subunits (Fig. 2A–E). To discard
experimental artifacts, we have verified the specificity of the an-
tibodies (data not shown). Western blotting showed that each
antibody selectively immunoprecipitated the respective target
protein and that GlyT2 coimmunoprecipitated with  and 
NKA subunits (Fig. 2A–D), indicating that native GlyT2 and
NKA proteins interact specifically under physiological condi-
tions. A significant percentage of GlyT2 interacted with 3
(13.01 1.92%), a minor amount with 2 (4.90 1.83%), and
very little with 1 (0.29  0.18%). In addition, the interaction
with  subunits was also detected, showing that 1.16 0.21% of
total GlyT2 copurified with 1 and 2.91 0.94% with 2. These
results would suggest that GlyT2 preferentially interacts with 3:
2-NKA complexes, but further studies would be needed to con-
clusively identify the NKA subunit to which GlyT2 interacts. The
3 isoform is widely distributed throughout the brain, but its
expression is restricted to neurons. By contrast, the 2 isoform is
mainly found in astrocytes throughout the adult brain, although
it is strongly expressed in neurons during development and it
persists in someneurons of the adult (Sweadner, 1989;McGrail et
Figure 1. Specific identification of Na/K-ATPase as an interacting partner of GlyT2. A, The histogram represents the spectral counts obtained frommass spectrometry corresponding to the
1,2,3,1, and2 subunits of NKA identified in the control (rabbit IgG immunoprecipitation, light gray) or anti-GlyT2 immunoprecipitations (dark gray). There is a significant increase in the
number ofNKAspectral counts identified in theGlyT2 immunoprecipitation.4 tubulin is shownas anexampleof nonspecific interaction thatwas identified equally in the controls and in theGlyT2
immunoprecipitations. GlyT2 spectral counts are identified only in the correct autoimmunoprecipitation. B–D, MS/MS spectra from the double-charged ions at m/z: 760.35, corresponding to the
SPDFTNENPLETR peptide (B); 716.88, corresponding to VLGFCQLNLPSGK peptide (C); and 1116.49, corresponding to TVNDLEDSYGQQWTYEQR peptide (D). These peptides were derived from the
1NKA,2NKA, and3NKA subunits, respectively.
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al., 1991; Juhaszova and Blaustein, 1997; Moseley et al., 2003;
Teixeira et al., 2003). Because the 1 isoform is expressed in all
cells, the magnitude of the interaction between GlyT2 and 3
subunit could be related to its specific neuronal expression. To
further investigate the interaction between GlyT2 and the differ-
ent NKA subunits, their colocalizationwas examined by immu-
nocytochemistry in primary neuronal cultures from brainstem
and spinal cord (Fig. 3). Double labeling for GlyT2 and NKA 
subunits (Fig. 3A–C) indicates that most GlyT2 overlaps with 3
subunit and shows amore limited colocalization with 2 and 1.
Given that GlyT2 is expressed in axons and nerve terminals and
NKA is enriched in synapses (Hilgenberg et al., 2006; Hazelwood
et al., 2008), we performed further immunofluorescence assays in
synaptosomes where the degree of colocalization between synap-
tic NKA and GlyT2 should be significantly higher. Indeed, in
addition to increasing the extent of colocalization betweenGlyT2
and 3 subunit, the quantitative differences in the colocalization
of the transporter and each of the three subunits are more clearly
manifested in this preparation (Fig. 4). Together, these immuno-
precipitation and immunocytochemical assays contribute to
show thatGlyT2 interacts specificallywithNKA inneurons. Con-
sidering these results and the neuron-specific expression of the
3 subunit andGlyT2, our further study is focused on theGlyT2-
NKA interaction by studying the 3 subunit of the NKA.
GlyT2–NKA interaction occurs in lipid rafts
We recently reported that GlyT2 displays optimal transport ac-
tivity when associatedwith lipid rafts in plasmamembranewhere
most of the transporter resides in primary neurons and synapto-
somes from the rat brainstem (Nu´n˜ez et al., 2008). Given that
NKA localizes in lipid rafts of several tissues (Taguchi et al., 2007;
Figure 2. The neuronal glycine transporter GlyT2 copurifies with Na/K-ATPase. A–D,
Synaptosomes from the rat brainstem and spinal cord were lysed and incubated at 4°C with
antibodies against GlyT2 (A,C), the1,2, or3 NKA subunit (B), the1 or2 NKA subunit
(D), or the equivalent IgGs as control (A–D). After a 1 h incubation with protein A (for rabbit
antibodies) or protein G (for goat andmouse antibodies) beads, the samples were precipitated
by mild centrifugation. The protein complexes were analyzed in Western blots probed with
anti-GlyT2 and anti-1, -2, -3, -1, or -2NKA subunit antibodies. T, Total protein (4g);
IP, immunoprecipitated sample (96g); IgG, IgG immunoprecipitation controls (96g). An
interaction can be detected betweenGlyT2 and theNKA isoforms (specificallywith3NKA), yet
no signal is observed with the IgG controls. C, Quantification of the percentage of GlyT2 inter-
actingwith the different NKA subunitswas calculated from the immunoprecipitations shown in
B. D, Normalizing against the amount of autoimmunoprecipitated  or  subunit. E, The
histogram represents themean SEM (IP1, n 3; IP2, n 5; IP3, n 8; IP1, n
3; IP2, n 3).
Figure 3. GlyT2 colocalizes with the3 subunit of the Na/K-ATPase in brainstem and
spinal cord primary neurons. A–D, Primary cultures of spinal cord and brainstem neurons were
grown on glass coverslips, fixed inmethanol at20°C, and incubated with antibodies against
GlyT2 and the 1 (A), 2 (B), or 3 (C) NKA subunits. After incubating with secondary anti-
bodies, the cells were visualized by confocal microscopy, showing GlyT2 in red andNKA sub-
units in green.D, Quantificationof colocalizationusingPearson’s value as described inMaterials
and Methods. The histogram represents the mean SEM (n 3; on average 30 images per
condition were analyzed in each experiment). *p 0.05, significantly different (Tukey’s post
hoc test). ***p 0.001, significantly different (ANOVA with Tukey’s post hoc test). There is
significantly enhanced colocalization of the GlyT2 and3 subunit of NKA, with respect to the
2 and1 subunits.
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Welker et al., 2007; Fujii et al., 2008; Liu et al., 2011; Tajima et al.,
2011), we investigated whether NKA and GlyT2 interact in these
membrane subdomains. Coimmunoprecipitation assays using
an anti-NKA 3 antibody (Fig. 5A) performed from raft and
nonraft fractions isolated through a sucrose gradient clearly in-
dicated that the interaction between the two proteins only oc-
curred in lipid rafts. The purity of the isolated fractions was
confirmed by the differential distribution of the raft and nonraft
markers flotillin1 and clathrin heavy chain (Fig. 5B). To detect
possible proteins thatmightmediate theGlyT2-NKA interaction,
we performedmass spectrometry analyses of GlyT2 immunopre-
cipitates from raft and nonraft fractions. Interestingly, NKA
spectral counts were predominantly identified in the raft frac-
tions confirming the restriction of the GlyT2-NKA complexes to
lipid raft subdomains (Fig. 5C). Further immunocytochemical
evidence of this distribution came from assays using specific an-
tibodies against GlyT2,3, and Thy-1, a marker of neuronal rafts
(Madore et al., 1999) (Fig. 6). The three proteins displayed a
similar distribution (Fig. 6A–G), leading to a high degree of triple
colocalization (Fig. 6H, I). As a control of the proteomic assay,
other molecules were restricted to nonraft fractions or found
evenly in both fractions. However, proteins other than the NKA
subunits that were found solely in the raft fraction were not likely
to be involved in GlyT2-NKA interactions at the plasma mem-
brane mainly because of their intracellular localization in native
cells. Nevertheless, to rule out such possibilities, more detailed
studies of these proteins would be necessary.
Ouabain effect on the transport activity and expression
of GlyT2
Lipid rafts are fluctuating nanoscale assemblies of sphingolipids,
cholesterol, and proteins that are stabilized into platforms im-
portant for signaling, viral infection, and membrane trafficking
(Simons and Gerl, 2010). As mentioned above (see Introduc-
tion), NKA also acts as a specific receptor for endogenous and
exogenous CTS through the formation of macromolecular com-
plexes in which  subunit acts as the anchor. CTS-activated NKA
signaling depends on the formation of specific signaling mi-
crodomains that couple NKA to its downstream effectors (Lin-
grel, 2010; Liu and Xie, 2010; Benarroch, 2011; Reinhard et al.,
2013). The ouabain binding site in NKA lies in the subunit, and
different isoforms of the  subunit have similar affinities for
ouabain, except for the rat and mouse 1 subunit, which is rela-
tively resistant to ouabain and has much lower affinity than the
other isoforms (103-fold to 104-fold) (for review, see Lingrel,
2010). Therefore, we examined the effect of different concentra-
tions of ouabain on GlyT2 function and protein expression. As
ouabain is known to inhibit NKA function, we determined the
effect of ouabain on NKA and GlyT2 transport activities in par-
allel experiments performed in brainstem and spinal cord neu-
rons (Fig. 7). A dose–response analysis of ouabain effect on the
activity of NKAwas performed bymeasuring 86Rb flux as a tracer
for potassium. The results showed that ouabain inhibits both
86Rb and [3H]-glycine uptake in a concentration-dependent
manner (Fig. 7A). Substantial inhibition was observed with 20
M ouabain (NKA, 55%; GlyT2, 45%), and concentrations50
M resulted in a nearly total inhibition. The tight correlation
observed between the ouabain-mediated inhibition of both
transporters may be explained by the strict dependence of GlyT2
function on the sodium electrochemical gradient that is mainly
generated andmaintained by NKA at the neuronal plasmamem-
brane. Because GlyT2 cotransports Na/Cl/glycine with a stoi-
chiometry of 3:1:1 (Lo´pez-Corcuera et al., 1998; Roux and
Supplisson, 2000), a functional relationship between the twopro-
teins is therefore not unexpected.
To elucidate the physiological role of the GlyT2-NKA interac-
tion, the effect of ouabain on the overall expression and the
plasmamembrane levels ofGlyT2were explored. Low (1M) and
high (50 M) inhibitor concentrations were used to compare
virtually unaltered activity with significant inhibition of the ion
pump, respectively. Biotinylation with the impermeable sulfo-
NHS-SS-biotin was quantified to detect changes in the cell sur-
face levels of GlyT2. Interestingly, a decrease in surface GlyT2
levels was detected in immunoblots when neurons were exposed
to 1M ouabain, a concentration that hardly affected NKA activ-
ity (Fig. 7B,D). This effect started within 1 h of ouabain treat-
ment, and larger reductions were observed after longer
exposures, whereas the total amount of GlyT2 remained unaf-
fected after 3 h of ouabain treatment. By contrast, general inhibi-
tion ofNKA activity by a high dose of ouabain (50M) drastically
reduced both the total and neuronal GlyT2 surface expression
(Fig. 7C,D). Because the reduction of total GlyT2 may be the
Figure 4. GlyT2 colocalizes with the3 subunit of the Na/K-ATPase in synaptosomes
fromadult rat brainstemand spinal cord.A–D, Synaptosomes isolated from the adult rat brain-
stemandspinal cordweredepositedonglass coverslips for 1h, fixed inmethanol at20°C, and
incubated with antibodies against GlyT2 and the1 (A),2 (B), or3 (C) NKA subunits. After
incubation with the secondary antibodies, the synaptosomes were visualized by confocal mi-
croscopy, showing GlyT2 in red andNKA subunits in green. D, Quantification of the colocal-
ization using Pearson’s value was performed as described in Materials and Methods, and the
histogram represents the mean SEM (n 3; on average, 30 images per condition were
analyzed in each experiment). ***p 0.001, significantly different (ANOVA with Tukey’s post
hoc test). There is significantly enhanced colocalization between GlyT2 and the3 subunit of
NKA over the2 and1 subunits.
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result of synthesis inhibition and/or increased degradation, we
assayed the effect of suppressing each of these cellular processes in
the presence or absence of ouabain to discern the reason behind
the decrease (Fig. 7E,F). The ouabain-induced reduction of
GlyT2 was completely prevented in the presence of leupeptin, a
lysosomal protease inhibitor. The partial effect exerted by the
proteasome inhibitorMG132 are probably the result of decreased
GlyT2 ubiquitination caused by depletion of the intracellular free
ubiquitin pool (Patnaik et al., 2000; Melikova et al., 2006). This
conclusion is based on our earlier results showing that endocyto-
sis and further sorting of GlyT2 to the recycling or degradation
pathways in neurons depends on ubiquitination, and that the
ubiquitination status of the transporter is highly sensitive to
ubiquitin homeostasis (de Juan-Sanz et al., 2013). In addition,
inhibition of lysosomal proteases by the proteasome blocker
MG132might be involved (Longva et al., 2002). The lack of effect
observed by 3 h treatment with cycloheximide, an inhibitor of the
protein synthesis, compared with the decrease in GlyT2 expres-
Figure 5. GlyT2-NKA interaction is compartmentalized to the lipid raft subdomains. A–C, Adult rat brainstem and spinal cord synaptosomes were lysed in ice-cold lysis buffer, and the lipid raft
fractions were isolated on a discontinuous sucrose density gradient as described in Materials andMethods. A, The membrane raft or nonraft fractions were pooled, adjusted to 100g in the same
volume, lysed at RT for 30min in lysis buffer to disrupt the remaining raft structures, and incubatedwith the antibody against3 NKA or the equivalent amount of goat IgG as control. After protein
G-Sepharose incubation, the protein complexes were separated by SDS-PAGE and probed with anti-GlyT2 antibody. T, Total protein (4 g); IP, immunoprecipitated sample (96 g), IgG, IgG
immunoprecipitation control (96g). GlyT2 only copurifies with the lipid raft-associated3NKA isoform, and no signal was observed in the IgG controls or from the nonraft immunoprecipitated
3NKA. B, For each experiment performed as in A, 10 g of raft and nonraft fractions were resolved by SDS-PAGE, and the Western blots were probed with anti-flotillin1 (raft marker) and
anti-clathrin heavy chain (CHC, nonraftmarker) to ensure the purity of the isolated fractions. C, The lipid raft and nonraft fractions isolated and lysed as inAwere incubatedwith anti-GlyT2 or rabbit
IgG, and recoveredwith protein A-Sepharose beads. The protein complexeswere digested, and the resulting peptideswere identified by high-throughputMS. The histogram represents the spectral
counts obtained from mass spectrometry corresponding to the 1, 2, 3, 1, and 2 subunits of NKA identified from raft and nonraft fractions. Light gray represents nonraft rabbit IgG
immunoprecipitation; dark gray, nonraft anti-GlyT2 immunoprecipitations;mediumgray, raft rabbit IgG immunoprecipitation; green, raft anti-GlyT2 immunoprecipitations.4 tubulin is shown as
an example of nonspecific peptides that were identified equally in the controls and in the GlyT2 immunoprecipitations. GlyT2 spectral counts are shown as a control for the correct autoimmuno-
precipitation. NKA subunits are more often detected in the lipid raft-associated GlyT2 immunoprecipitates (specifically3 NKA).
Figure 6. Triple colocalization of GlyT2,3NKA, and the lipid raft marker Thy-1 in brainstem and spinal cord primary neurons. A–I, Primary cultures of spinal cord and brainstem neurons were
grown on glass coverslips, fixed in methanol at20°C, and incubated with primary and secondary antibodies against GlyT2 (green),3NKA (red), and the lipid raft marker Thy-1 (blue). The cells
were visualized by confocal microscopy, and triple colocalizationmaps were generated using a colocalization color map plugin to denote the regions of triple colocalization, showing themaximum
colocalization pixels in red and the minimum colocalization pixels in blue. GlyT2-3NKA colocalization cocompartmentalizes extensively with the lipid raft Thy-1 clusters.
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sion caused by a similar treatment of
ouabain, suggests that degradation, but
not protein synthesis, underlies the reduc-
tion of GlyT2 levels (Fig. 7F). Together,
these results indicate that NKA-dependent
reduction of GlyT2 expression ismainly the
result of an increase in its lysosomal degra-
dation. To investigate whether ouabain-
mediated GlyT2 degradation was a more
general effect, the expression of GlyT2-
relatedneuronalproteinswasassessed in the
presenceof50Mouabain. Syntaxin1Aand
CRMP5/Ulip6have been identified as bind-
ing partners ofGlyT2 (Geerlings et al., 2001;
Horiuchi et al., 2005), the serotonin and
GABA transporters (SERT and GAT1, re-
spectively), like GlyT2, are members of the
SLC6 gene family. Finally,1 and3 are the
most abundant NKA subunits in neurons.
Interestingly, no changes were detected in
the expression of these proteins after 3 h of
treatment with 50 M ouabain, suggesting
that downregulation of GlyT2 by NKA was
selective (Fig. 7C,G).
Then we asked whether the fact that
GlyT2-NKA interaction takes place in
rafts (Fig. 5) could have functional impli-
cations and hence participate in the
ouabain-mediated degradation of GlyT2.
Accordingly, we isolated lipid rafts from
primary cultures of brainstem and spinal
cord neurons previously treated with 50
M ouabain and GlyT2 levels in raft and
nonraft fractions were immunodetected by
Western blot (Fig. 8A). Interestingly, most
of the ouabain-induced GlyT2 degradation
occurred in raft fractions whereas GlyT2 lo-
cated outside the rafts remained unaffected.
Because GlyT2 must be located in rafts for
optimal transport activity, our results
strongly suggest that NKA exerts a regula-
tory role selectively on the cell surfaceGlyT2
lipid raft-associated pool. Furthermore, the
disruption of lipid rafts by the cholesterol
chelator nystatin completely blocked
ouabain-mediated GlyT2 degradation (Fig.
8B). Therefore, in addition to providing the
appropriate environment for optimal
GlyT2 activity and consistent with their role
as signaling platforms, lipid rafts constitute
the plasma membrane subdomains where
the neuronal GlyT2-NKA interaction regu-
lates the endocytosis and subsequent degra-
dation of GlyT2.
Ouabain-mediated degradation of
GlyT2 occurs in vivo in distinct species
Because ouabain is an endogenously pro-
duced compound (Hamlyn et al., 1991; el-Masri et al., 2002), we
investigated whether the regulation of GlyT2 observed in vitro in
the primary cultures of rat brainstem and spinal cord neurons
also occurred in vivo. To test this hypothesis, we first studied the
zebrafish (Danio rerio) embryo, a firmly establishedmodel widely
used to investigate drug effects, CNS development, mechanisms
of neurological disease, and even behavioral neuroscience (for
review, see Levin and Cerutti, 2009; Cheng et al., 2011; Xi et al.,
2011). Furthermore, the extended distribution of glycinergic
neurons and GlyT2 has been widely studied (Higashijima et al.,
Figure 7. Functional coupling between Na/K-ATPase and GlyT2. A, Concentration-dependent inhibition of 86Rb uptake
(NKA activity) and [ 3H]-glycine transport (GlyT2 transport) by ouabain (20min) in brainstemand spinal cord primary neurons. The
results are expressed as the percentage of control cells maintained in the absence of ouabain, and each point represents the
mean SEM of four experiments performed in triplicate. B, C, Representative immunoblot of primary brainstem and spinal cord
neuronal cultures. Cells were treated with ouabain at 1M (B) or 50M (C) for the times indicated. After labeling the cell surface
proteinswith sulfo-NHS-SS-biotin and recovering the biotinylated proteinswith streptavidin-agarose beads, the surface and total
expression of GlyT2 and3NKAwere analyzed inWestern blots. Tubulin immunodetectionwas used as a nonbiotinylated protein
control. 2, 4, Biotinylatedprotein (16g). 1, 3, Total protein (8g).D, Degradation curvesweregeneratedbymeasuring theGlyT2
band densities and normalizing them to the corresponding tubulin densities in the total protein (1 and 3), or to the corresponding
surface3NKA band densities in surface proteins (2 and 4), and designating time 0 as 100%. The black curves correspond to the
total GlyT2 concentrations after exposure to 1M (1) or 50M (3) ouabain, and the gray curves correspond to the surface GlyT2
levels after exposure to 1M (2) or 50M (4) ouabain. Densitometric analysis was performed on five independent Western blots
(as in B and C), representing the mean SEM. E–G, Representative immunoblots of primary brainstem and spinal cord neuron
cultures. E, Neurons were pretreatedwith the vehicle alone (veh), leupeptin (leupt), or MG132 for 3 h, and then 50M ouabain or
the vehiclewas added for a further 3hwhilemaintaining thepretreatment.WhenGlyT2 expressionwas analyzed inWesternblots,
GlyT2 degradationwas significantly blocked by leupeptin treatment. F, Neurons were treatedwith 10g/ml cycloheximide or 50
Mouabain and the respective vehicles (veh) for 3 h, andGlyT2 expressionwas assessed inWestern blots.G, Neuronswere treated
with thevehicle aloneorwith50Mouabain, and theexpressionof the followingGlyT2-associatedproteinswasassessed:1NKA,
syntaxin1A (STX1A), serotonin transporter (SERT), CRMP5, and GABA transporter 1 (GAT1).
14276 • J. Neurosci., August 28, 2013 • 33(35):14269–14281 de Juan-Sanz et al. • Downregulation of GlyT2 by Na/K-ATPase Interaction
2004a, b; Cui et al., 2005;Moly andHatta, 2011; Barreiro-Iglesias
et al., 2013). Recently, it became also evident that zebrafish is a
valuable model for investigating NKA subunit functions
(Doðanli et al., 2012, 2013). In zebrafish, CNS drug tests must be
performed before the blood–brain barrier is fully formed to en-
sure that the compound reaches its neuronal targets, a process
that ends 3 d after fertilization (72 hpf) when the embryo is ready
to hatch. Thus, drug screening is usually performed on dechorion-
ated embryos at earlier stages. GlyT2 expression in zebrafish em-
bryos starts at 20 hpf (Higashijima et al., 2004a), augmenting over
time and being clearly detected at 36–48 hpf (Higashijima et al.,
2004b; Cui et al., 2005; Moly and Hatta, 2011). Moreover, 48 hpf
zebrafish embryos expressed both 3NKA and GlyT2, which colo-
calized extensively in the central brain, hindbrain, and spinal cord,
being clearly observed in dorsal interneurons (Fig. 9A–F) (Higashi-
jimaetal., 2004a,b;Cuiet al., 2005;MolyandHatta,2011).Whenwe
treated dechorionated 48 hpf zebrafish embryos with a high dose of
ouabain for 6 h and analyzed GlyT2 expression in Western blots,
there was a significant reduction in GlyT2 expression (remaining
only 6.74 4.54%SEMof the initial amount), whereas tubulin and
3NKAwereunaffected (Fig. 9G,H). These data confirmedour ear-
lier in vitro results indicating the importance of GlyT2 regulation by
NKA in vivoandsuggesting that thismechanismis conservedamong
different vertebrates.
To study the ouabain-mediated degradation of GlyT2 in
mammals in vivo, we injected ouabain intramedullary into adult
rats (Fig. 10). As GlyT2 is expressed along the spinal cord, we
administered ouabain to the mid region at T8. Three hours after
ouabain administration, the anesthetized animals were killed and
different sections of the spinal cord (C4, T8, and T12) were ex-
tracted, lysed, and analyzed in Western blots (Fig. 10A,B). Al-
though injection of the vehicle alone producedno effect onGlyT2
expression, ouabain reduced the levels of GlyT2 locally at the site
of injection (T8) but not in the other spinal cord regions exam-
ined (C4, T12). Together, these results indicate that GlyT2 is
degraded in vivo in the presence of ouabain in zebrafish embryos
and adult rats, suggesting an evolutionarily conserved mecha-
nism to downregulate GlyT2 through its interacting partner
Na/K-ATPase, which consequently modulates the inhibitory
glycinergic neurotransmission.
Discussion
In the present study, we used high-throughput mass spectrome-
try to identify proteins that interact with GlyT2 in CNS prepara-
tions to unravel new mechanisms that might modulate GlyT2
function. In this way, we identified NKA as a new protein partner
of GlyT2. This novel interaction regulates the endocytosis and
total expression of GlyT2 in neurons. Our reciprocal coimmuno-
precipitation and immunocytochemical studies further con-
firmed proteomic data and indicated that GlyT2 associates and
colocalizes with NKA in neurons and synaptosomes. Given that
functional NKA is composed by tightly bound  and  subunits,
our immunoprecipitation results would lead to speculation that
GlyT2 predominantly interacts with 3:2-NKA functional
pumps. However, the methodology used in this study does not
identify which subunit of the NKA is responsible for the interac-
Figure 8. Ouabain-mediated degradation of lipid raft-associated GlyT2. A, Brainstem and
spinal cord primary neurons were treatedwith 50M ouabain or the vehicle alone for 3 h, they
were lysedwith ice-cold lysis buffer, and the lipid raft fractionswere isolated on adiscontinuous
sucrosedensity gradient (as described inMaterials andMethods). Themembrane raft or nonraft
fractions were pooled, adjusted to 100g in the same volume, and they were maintained at
37°C for 30 min in lysis buffer before measuring GlyT2 expression. Flotillin1 is shown to dem-
onstrate the purity of the isolated fractions. There is significant degradation of the lipid raft-
associated GlyT2 pool. B, Neurons were pretreated with the vehicle alone (DMSO) or nystatin
(Nys) for 3 h, after which 50 M ouabain or the vehicle alone was added for a further 3 h,
maintaining the previous pretreatment. The nystatin-mediated disruption of raft subdomains
impaired GlyT2 degradation. **p 0.01, ***p 0.001, significantly different (ANOVA with
Tukey’s post hoc test). n.s., Not significant.
Figure 9. GlyT2-3NKA colocalization and ouabain-mediated degradation of GlyT2 in ze-
brafish embryos.A–F, Dechorionated zebrafish embryos (48 hpf)were fixed in 4%PFA, perme-
abilized, immunostained for GlyT2 (green) and 3NKA (red), and visualized by confocal
microscopy.A–C,Whole-mount images of zebrafish embryos.D–F, Examples showing colocal-
ization of3NKA and GlyT2 in dorsal interneurons. Scale bar, 10m. G, Seven dechorionated
zebrafish embryos (48 hpf) per condition were maintained in E3 medium in the presence or
absence of 100Mouabain for 6 h. Subsequently, all the embryos for each conditionwere lysed
together, and GlyT2 expression was measured. Tubulin and3NKA are shown as loading con-
trols. There is significant reduction in GlyT2 expression but no changes in tubulin or3NKA.H,
The histogram represents the mean SEM of five experiments performed as in G. ***p
0001, significantly different (Student’s t test).
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tion. Thus, further studies would be
needed to conclusively determine the
NKA subunit to which GlyT2 interacts
(3 or 2 or both). NKA 3 subunit is
specifically expressed in neurons (Do-
bretsov and Stimers, 2005), and it is
mainly located presynaptically and post-
synaptically (Hilgenberg et al., 2006; Kim
et al., 2007). This subunit plays a crucial
role in regulating membrane potential,
and it mediates the rapid recovery of high
intracellular Na concentrations after in-
tense synaptic activity (Kim et al., 2007;
Azarias et al., 2013). Thus, the large num-
ber of severe neurological disorders asso-
ciated with human 3 mutations is not
surprising. 3NKA alterations can be the
cause of rapid-onset dystonic parkinson-
ism (de Carvalho Aguiar et al., 2004; Bras-
hear et al., 2007), cognitive defects
(Lingrel et al., 2007; Moseley et al., 2007),
mood disorders (Kirshenbaum et al.,
2011a, b), and alternating hemiplegia of
childhood (Heinzen et al., 2012).
One important finding of this work
is that the GlyT2-NKA interaction is
restricted to lipid raft membrane sub-
domains, as demonstrated by coimmuno-
precipitation from raft fractions and the
triple colocalization between GlyT2,
3NKA, and the neuronal raft marker
Thy-1.These resultswere further confirmed
byproteomic analysiswhere spectral counts
corresponding to the1,2,3,1, and2
subunits of NKA were predominantly ob-
served in GlyT2 immunoprecipitates from raft fractions. This
GlyT2-NKAmembrane compartmentalization favors their interac-
tion by increasing the likelihood of contact andmay have functional
implications in maintaining local synaptic sodium homeostasis.
Thus, by providing the energy required for glycine transport, the
presence of NKA in rafts is essential for the efficient functioning of
GlyT2. Furthermore, the interaction with the active population of
GlyT2 in rafts allowsNKA to restore the accumulation of intracellu-
lar Na after the transporter activity in the presynaptic terminal.
GlyT2 cotransports 3 Na for each glycine recovered from the syn-
aptic cleft (Lo´pez-Corcuera et al., 1998;RouxandSupplisson, 2000),
and it is theonly transporterof theSLC6 family thatneedsmore than
two Na ions for transport coupling. During activity in the nerve
terminal, neurotransmitter exocytosis produces a rapid and tran-
sient increase in the amount of GlyT2 in the plasma membrane,
which favors the rapid reuptake and recycling of glycine into the
terminal (Geerlings et al., 2001). In this situation, a rapid local in-
crease in intracellular [Na] occurs because of GlyT2 activity. The
neuronal specific3NKA subunit has a crucial role in the control of
the membrane potential and the fast recovery of high intracellular
Na concentrations after intense synaptic activity (Kim et al., 2007;
Azarias et al., 2013), so it is tempting to speculate that NKA com-
plexes containing the neuronal specific subunit 3 will rapidly re-
store the rapid local increase in intracellular [Na] producedduring
GlyT2 activity in the presynaptic terminal.
In this regard, our 86Rb-flux and glycine transport experi-
ments in the presence of ouabain show a tight correlation in the
inhibition of NKA and GlyT2 activities that is indicative of the
strict functional dependence of GlyT2 on the sodium electro-
chemical gradient generated by the ion pump. Because GlyT2
cotransports 3Na/Cl/glycine and the stoichiometry of the
NKA catalytic cycle is 3Na/2K/ATP, a functional relationship
and physical association between the two proteins may represent
a suitablemolecular device for the inhibitory glycinergic synapse.
Low concentrations of ouabain (1 M), which did not signifi-
cantly affect the global Na gradient, induced GlyT2 endocyto-
sis, which could be detected in neurons 1 h after ouabain
treatment. When the overall sodium gradient in the neuron was
severely compromised by high concentrations of ouabain (50
M), significant time-dependent lysosomal degradation of the
transporter was observed in addition toGlyT2 endocytosis. Thus,
when 3NKA is inhibited by 1 M ouabain GlyT2 is removed
from the cell surface to prevent further local depolarization and
dissipation of the Na gradient in the presynaptic membrane.
Moreover, higher ouabain levels produce a more drastic effect by
irreversibly degrading GlyT2 and preventing its recycle back to
themembrane. Accordingly, our data suggest that NKA regulates
GlyT2 recycling and turnover in the glycinergic synapse by a
feedback mechanism used to maintain the membrane potential
and intracellular sodium homeostasis. Given that the exclusively
neuronal3NKA seems to be themainNKA interacting partner
of GlyT2 and considering the important role that this subunit
plays in controlling high intracellular sodium concentration dur-
ing synaptic activity (Kim et al., 2007; Azarias et al., 2013), our
results suggest that 3NKA could be themainmediator of GlyT2
downregulation by ouabain treatments. A regulatorymechanism
Figure 10. Intramedullar administration of ouabain to adult rats provokes the degradation of GlyT2 in vivo. A–C, After anes-
thetizing adult rats, 2l of the vehicle or 2l of 1 mM ouabain was injected intramedullary into each animal at the level of T8 of
the spinal cord. Three hours later the animals were killed, and different sections of the spinal cord were extracted, lysed, and
analyzed byWestern blot. The sections studiedwere from C4, T8, and T12.B, The histogram represents themean SEM (n 4).
*p 0.05, significantly different (ANOVA with Tukey’s post hoc test). There is reduced GlyT2 expression after ouabain adminis-
tration in vivo that does not occur in other proteins, such as-III tubulin, syntaxin 1A (STX1A), or CRMP5 (C). The scheme shows the
different spinal cord sections extracted after ouabain administration in vivo. Red represents the site of ouabain injection.
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similar to that described here for GlyT2 was identified for the
GluR1 subunit of the AMPA receptor in hippocampal neurons.
Through the interaction of 1NKA with GluR1, the surface and
total expression of GluR1 decrease in response to high concen-
trations of ouabain (Zhang et al., 2009). Furthermore, the gluta-
mate transporters GLAST and GLT-1 are physically associated
with 2/3NKA within a single macromolecular complex in the
plasma membrane through which the NKA regulates the trans-
porter function and hence the glutamatergic neurotransmission
(Rose et al., 2009). Together, these data suggest that the mecha-
nism described here and elsewhere could represent a more gen-
eral process underlying synaptic plasticity wherebyNKA controls
neuronal proteins whose activity in the synaptic membrane con-
tributes to increasing intracellular Na in neurons.
The physiologically relevant role of lipid rafts in regulating
GlyT2 through its interaction with NKA is even more evident
when we observe that ouabain-mediated degradation of GlyT2
mainly affects the active raft-associated population of this trans-
porter. The fact that both endocytosis and degradation of GlyT2
are slow responses to ouabain is not consistent with the rapid
depletion of the Na gradient observed (after a 20 min exposure
to ouabain), implying that the mechanism underlying NKA-
mediated downregulation of GlyT2 does not depend directly on
changes in the ion gradient in the neuronal membrane but rather
involves a process that takes longer to activate. In this regard, it is
noteworthy that the two roles of NKA as an ion pump and a CTS
receptor coupled to signaling pathways are not mutually exclu-
sive because they can work in concert to control cellular function
(Li and Xie, 2009), as confirmed by the GlyT2 downregulation
seen in this study. However, further studies will be required to
identify this molecular mechanism, which probably involves sig-
naling pathways downstream of NKA.
It has been well established that the neuronal transporter
GlyT2 recycles the neurotransmitter to the presynaptic terminal,
being the main supplier of glycine for constitutive vesicle re-
filling. This process is absolutely necessary to preserve the
quantal glycine content inside synaptic vesicles, and it is crit-
ical for regulating inhibitory synaptic strength (Gomeza et al.,
2003b; Rousseau et al., 2008; Apostolides and Trussell, 2013).
Therefore, because GlyT2 activity regulates inhibitory synap-
tic strength, the new modulatory mechanism described here
acquires great relevance.
Gene deletion studies suggest that GlyT2 alterations may un-
derlie several neuromuscular disorders, such as hyperekplexia,
myoclonus, and epilepsy (Gomeza et al., 2003b; Arago´n and
Lo´pez-Corcuera, 2005). Indeed, mutations in the gene encoding
GlyT2 are the major presynaptic cause of hyperekplexia in hu-
mans (Eulenburg et al., 2006; Rees et al., 2006; Carta et al., 2012;
Gimenez et al., 2012) and produce CMD2 in Belgian Blue cattle
(Gill et al., 2012). Moreover, neurological disorders associated
with human 3 mutations, such as rapid-onset dystonia parkin-
sonism (de Carvalho Aguiar et al., 2004; Brashear et al., 2007),
alternating hemiplegia of childhood (Heinzen et al., 2012), and a
mouse (Myk/) model for epilepsy caused by a mutation of the
NKA 3 isoform (Clapcote et al., 2009), present alterations in
motor control, such as epilepsy, dystonia, and others. Consider-
ing that both GlyT2 and 3 isoforms are exclusively neuronal
proteins, it is tempting to speculate that pathological mutations
of3 isoform negatively affect GlyT2 activity, leading to a glycin-
ergic neurotransmission depletion that could contribute to the
observed phenotype.
Finally, we have demonstrated that ouabain-induced GlyT2
downregulation by degradation also occurs in vivo in zebrafish
embryos and adult rats, indicating that this GlyT2 regulatory
mechanism involving NKA is evolutionarily conserved. Remark-
ably, this work started with an in vitro proteomic analysis reveal-
ing potential interacting candidates for GlyT2, and it concluded
revealing a new in vivo evolutionarily conserved mechanism that
regulates this relevant presynaptic transporter by the action of an
endogenously produced hormone. Thus, slight increases in the
amount of ouabain at glycinergic synapses could cause a decrease
of GlyT2 at the cell surface, and high ouabain levels may induce a
more drastic GlyT2 downregulation by additional degradation of
the transporter. Both effects would lead to a reduction in the
glycine refilling of synaptic vesicles further decreasing the inhib-
itory glycinergic neurotransmission.
Notes
Supplemental material for this article is available at http://www.cbm.
uam.es/doc/ProteomicDataJS/. Proteomic data are from Figures 1 and 5.
This material has not been peer reviewed.
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